4//SEC Filing
van der Kamp Hilde Johanna 4
Accession 0001193125-26-009274
CIK 0001936258other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 7:34 PM ET
Size
7.2 KB
Accession
0001193125-26-009274
Insider Transaction Report
Form 4
van der Kamp Hilde Johanna
Director
Transactions
- Award
Ordinary Shares
2026-01-07+3,400→ 10,360 total - Award
Option (right to buy)
2026-01-07+15,300→ 15,300 totalExercise: $35.45Exp: 2036-01-07→ Ordinary Shares (15,300 underlying)
Footnotes (3)
- [F1]Represents restricted stock units (RSUs), each representing a contingent right to receive one ordinary share. All of the RSUs will vest on the one-year anniversary of the vesting start date, subject to the Reporting Person's continued service through such date.
- [F2]Each RSU was granted on January 7, 2026 for no consideration.
- [F3]All of the ordinary shares underlying the option will vest on January 2, 2027, the one-year anniversary of the vesting start date, subject to the Reporting Person's continued service through such date.
Documents
Issuer
NewAmsterdam Pharma Co N.V.
CIK 0001936258
Entity typeother
Related Parties
1- filerCIK 0002000565
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 7:34 PM ET
- Size
- 7.2 KB